Interneuron’s dexfenfluramine
Executive Summary
NDA filed for the anti-obesity drug, company reports May 24. Licensee American Cyanamid will pay $2.5 mil. in cash and purchase $500,000 in preferred stock as a milestone payment. Cyanamid paid $2 mil. and purchased $3 mil. in stock in November at the time of its initia licensing agreement.